---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-24-000163"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:49:09.745295+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Globus Medical shareholders approve amendment to 2021 Equity Incentive Plan

## Summary
- Plan amendment approved with 244,115,224 votes for, 78,950,353 against; effective June 5, 2024.
- Material features described in Proxy Statement filed April 26, 2024, incorporated by reference.
- Directors elected: Davidar (263.7M for), Tobin (256.5M), Zarrilli (320.0M), Wolterman (322.5M).
- Ratification of Deloitte as auditor (329.3M for) and non-binding say-on-pay approved (315.4M for).

## SEC filing metadata
- accession: 0001562762-24-000163
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000163/0001562762-24-000163-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000163/gmed-20240605x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-24-000163
- JSON: https://secwatch.observer/filing/0001562762-24-000163.json
- Plain text: https://secwatch.observer/filing/0001562762-24-000163.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.